These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 24035784)

  • 1. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
    Johnson B; Opimba M; Bernier J
    Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
    Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper-O-GlcNAcylation inhibits the induction of heat shock protein 70 (Hsp 70) by sodium arsenite in HeLa cells.
    Miura Y; Sato T; Sakurai Y; Sakai R; Hiraoka W; Endo T
    Biol Pharm Bull; 2014; 37(8):1308-14. PubMed ID: 25087952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.
    Xing D; Feng W; Nöt LG; Miller AP; Zhang Y; Chen YF; Majid-Hassan E; Chatham JC; Oparil S
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H335-42. PubMed ID: 18469144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc modification of proteins affects volume regulation in Jurkat cells.
    Nagy T; Balasa A; Frank D; Rab A; Rideg O; Kotek G; Magyarlaki T; Bogner P; Kovács GL; Miseta A
    Eur Biophys J; 2010 Jul; 39(8):1207-17. PubMed ID: 20043149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
    Matthews JA; Acevedo-Duncan M; Potter RL
    Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
    Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
    Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cells.
    Xing D; Gong K; Feng W; Nozell SE; Chen YF; Chatham JC; Oparil S
    PLoS One; 2011; 6(8):e24021. PubMed ID: 21904602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.
    Drougat L; Olivier-Van Stichelen S; Mortuaire M; Foulquier F; Lacoste AS; Michalski JC; Lefebvre T; Vercoutter-Edouart AS
    Biochim Biophys Acta; 2012 Dec; 1820(12):1839-48. PubMed ID: 22967762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans.
    Lee J; Kim KY; Lee J; Paik YK
    J Biol Chem; 2010 Jan; 285(5):2930-9. PubMed ID: 19940149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.